Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement - Horneff, G; Fitter, S; Foeldvari, I (Arthritis Res Ther, 2012)
et al.